160 results on '"Unterecker S"'
Search Results
2. Equal contribution of pharmacogenetic phenotype and phenoconversion to functional CYP2D6 metabolizer status
3. Sertraline concentration in serum unaffected by hemodialysis: a case report
4. Drug-drug interaction between hydroxybupropion and venlafaxine – a pharmacokinetic study on CYP2D6
5. Nöropsikofarmakolojide Terapötik İla ç İzlemi İ çin Ortak Görü ş Kılavuzu: 2017 G üncellemesi
6. Therapeutic Drug Monitoring (TDM) of Antidepressants for the Treatment of Chronic Musculoskeletal Pain With and Without Depression
7. Effects of anxious depression on antidepressant treatment response
8. Therapeutic drug monitoring of tricyclic antidepressants in everyday clinical practice
9. Therapeutic drug monitoring of sertraline in pediatric population: A naturalistic study with insights into the clinical response of obsessive-compulsive disorder
10. Antidepressants in pregnancy – focus on therapeutic drug monitoring
11. Tools for optimising pharmacotherapy in psychiatry (therapeutic drug monitoring, molecular brain imaging and pharmacogenetic tests): focus on antidepressants
12. Effects of gender and age on serum concentrations of antidepressants under naturalistic conditions
13. Tools for optimising pharmacotherapy in psychiatry (therapeutic drug monitoring, molecular brain imaging and pharmacogenetic tests) : focus on antidepressants
14. Tools for optimising pharmacotherapy in psychiatry (therapeutic drug monitoring, molecular brain imaging and pharmacogenetic tests): focus on antidepressants
15. Elevated clozapine serum levels in combination with perazine
16. 8 Serum concentrations of venlafaxine and risperidone and their metabolites from childhood to old age
17. 21 Therapeutic drug monitoring of antidepressants in chronic pain treatment
18. 13 Therapeutic drug monitoring in pregnancy and post-partum period – antidepressant substances
19. Vitamin D level and depression in psychogeriatric patients
20. Antipsychotics in routine treatment are minor contributors to QTc prolongation compared to genetics and age
21. Drug-drug interactions between lithium and antihypertensive and anti-inflammatory drugs
22. Drug-drug interaction between hydroxybupropion and venlafaxine: A pharmacokinetic study on CYP2D6
23. Investigation of metabolite to parent compound ratios of venlafaxine and risperidone in minors
24. Antidepressant effects of augmentative transcranial magnetic stimulation: Randomised multicentre trial
25. Θεραπευτική παρακολούθηση φαρμάκων στην Ψυχιατρική και στη Νευρολογία Κατευθυντήριες Οδηγίες στη Νευροψυχοφαρμακολογία, επικαιροποίηση 2017.
26. Increased C-reactive protein concentrations is associated with increased concentrations of quetiapine
27. Therapeutic drug level measurement in breast milk
28. Differences in the pharmacokinetics of psychopharmacological drugs between smokers and nonsmokers
29. Consensus Guidelines for Therapeutic Drug Monitoring in Neuropsychopharmacology: Update 2017
30. Consensus Guidelines for Therapeutic Drug Monitoring in Neuropsychopharmacology: Update 2017
31. Individualizing psychopharmacological treatment – considering therapeutic drug monitoring and pharmacogenetics
32. Association between body weight and serum concentration of antidepressant drugs
33. QTc prolongation of amitriptyline and doxepin in relation to serum concentration and method of frequency correction
34. Retrospective Pilot Study for Analysis of Antidepressant Serum Concentrations of Citalopram and Venlafaxine during Inflammation
35. SLC6A2 and SLC6A4 Variants interact with Venlafaxine Serum Concentrations to Influence Therapy Outcome
36. Therapeutic drug monitoring of tricyclic antidepressants in everyday clinical practice
37. SLC6A2 and SLC6A4 Variants interact with Venlafaxine Serum Concentrations to Influence Therapy Outcome
38. Interaction between valproic acid and antidepressants/antipsychotics
39. Case report: Interaction of valproic acid and the antidepressant drug doxepin
40. Predictable interaction between lithium and ACE inhibitors or diuretics?
41. Methodological problems arising from false-positive drug-screenings
42. Mild outcome after overdose of venlafaxine and zopiclone
43. Relation between dosage, serum concentration and therapeutic response of risperidone in children and adolescents with schizophrenic psychosis: data from a routine TDM-Service
44. Dried Blood Spot Analysis – the next level of therapeutic drug monitoring?
45. EPA-1097 - False positive phencyclidine drug screenings during psychopharmacologic treatment
46. The influence of gender, age, smoking habit and body weight on serum levels of antiepileptic drugs under naturalistic conditions
47. Effects of gender and age on serum concentrations of antidepressants under naturalistic conditions
48. Interaction of valproic acid and antidepressant drugs
49. The Effect of Age, Sex, Smoking and Co-Medication on Serum Levels of Venlafaxine and O-Desmethylvenlafaxine under Naturalistic Conditions
50. Correlation of QTc Interval Prolongation and Serum Level of Citalopram after Intoxication – A Case Report
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.